Metabolic effects of discontinuing growth hormone treatment
F J Cowanb, W D Evansa, J W Gregoryc
a Department of
Medical Physics, University Hospital of Wales Healthcare NHS Trust,
Heath Park, Cardiff CF4 4XW, UK, b Department of Child Health, University
Hospital of Wales Healthcare NHS Trust, c Department of Child Health, University of
Wales College of Medicine, Heath Park, Cardiff CF4 4XN, UK
Correspondence to: Dr Gregory.
Accepted 22 December
1998
AIMS
To evaluate the
effects of discontinuing growth hormone (GH) treatment on energy
expenditure and body composition, which might help predict those most
likely to benefit from early reintroduction of GH treatment in young
adult life.
METHODS
Body
composition was calculated from skinfold thicknesses and dual energy
x ray absorptometry (DXA). Resting metabolic
rate (RMR) and whole body bone mineral content (BMC) were also
measured. Measurements were made before stopping treatment, at
discontinuation of GH treatment, and two weeks, six months, and one
year later in 11 adolescents with growth hormone deficiency (GHD) and
five adolescents without GHD who were treated with GH. Measurements were compared with 10 healthy controls, in whom measurements were repeated one year later.
RESULTS
During the
nine months before discontinuation of GH there were no changes in body
composition, RMR, or BMC of patients with GHD, nor differences when
compared with controls. RMR was reduced by 11.3 kJ/kg fat free mass
two weeks after stopping GH in GHD patients and remained suppressed
thereafter compared with controls. Percentage body fat increased by
4.3%/year in patients with GHD after discontinuing GH, whereas no
changes were noted in control or non-GHD patients at one year. The
patients experiencing the greatest reductions in RMR/kg fat free mass
at six months showed the largest increases in body fat at one year. No
change in BMC was noted in patients one year after stopping treatment.
CONCLUSION
Important
metabolic changes occur early after discontinuing GH treatment.
In patients whose growth is complete, these changes might be used to
predict those most likely to benefit from continuation of GH treatment
into adult life.
Keywords: growth hormone deficiency; body composition; resting metabolic rate; bone mineralisation
© 1999 by Archives of Disease in Childhood
This article has been cited by other articles:
-
Mauras, N., Pescovitz, O. H., Allada, V., Messig, M., Wajnrajch, M. P., Lippe, B., on behalf of the Transition Study Group,
(2005). Limited Efficacy of Growth Hormone (GH) during Transition of GH-Deficient Patients from Adolescence to Adulthood: A Phase III Multicenter, Double-Blind, Randomized Two-Year Trial. J. Clin. Endocrinol. Metab.
90: 3946-3955
[Abstract] [Full Text] -
Hoos, M. B., Westerterp, K. R., Gerver, W.-J. M.
(2003). Short-Term Effects of Growth Hormone on Body Composition as a Predictor of Growth. J. Clin. Endocrinol. Metab.
88: 2569-2572
[Abstract] [Full Text] -
Sas, T., Mulder, P., Hokken-Koelega, A.
(2000). Body Composition, Blood Pressure, and Lipid Metabolism before and during Long-Term Growth Hormone (GH) Treatment in Children with Short Stature Born Small for Gestational Age Either with or without GH Deficiency. J. Clin. Endocrinol. Metab.
85: 3786-3792
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



